Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

epoprostenol

epoprostenol
  • Restricted Veletri (IV) --> restricted to pulmonology/medical-intensivist, cardiology, rheumatology, and pediatric critical care
  • Restricted Miscellaneous
  • Non-formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Flolan POWDER FOR INJECTION, INTRAVENOUS 0.5 mg, 1.5 mg      
Veletri POWDER FOR INJECTION, INTRAVENOUS 0.5 mg, 1.5 mg      

High Alert Drug : Policy

Comments:

Intravenous epoprostenol may be administered through inhalation utilizing the approved PowerPlan.


VELETRI for IV injection is classified as formulary status, restricted to pulmonology/medical-intensivist, cardiology, rheumatology, and pediatric critical care. Stock as needed.

 

VELETRI for Inhalation is classified as formulary status, restricted to pulmonology/medical-intensivists, cardiothoracic surgeons, anesthesiologists, trauma surgeons, and cardiologist.

   ***Inhaled epoprostenol is dosed on ideal body weight rounded to the nearest 5 kg***

Ideal body weight calculation:

    • Females: 45.5 kg + 2.3 kg for every inch over 5 feet
    • Males: 50 kg + 2.3 kg for every inch over 5 feet

Inhaled VELETRI tip sheet, Inhaled VELETRI dosing guideline

 


FLOLAN is classified as non-formulary, not stocked. Flolan is automatically interchanged to VELETRI.

Veletri is available through two specialty pharmacies:

  1. Accredo Health Group, Inc.
    • Phone: 1-866-Fight-PH (1-866-344-4874)
    • Fax: 1-866-254-2313
  2. CVS Caremark, L.L.C
    • Phone: 1-877-242-2738
    • Fax: 1-877-943-1000

Ordering Veletri -- Enrollment form must be completed and signed by a prescriber

  • Click Here to visit site
  • Download the "enrollment form"
  • Complete enrollment form and fax to one of the above specialty pharmacy locations

 


Reviewed: April 27, 2005 (FLOLAN) and 26 May 2015 (Veletri/Flolan), Jan 2021 (Intravenous epoprostenol)

Updated: November 2022 (inhalation)


Last updated: Nov. 30, 2022







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.